Cue Biopharma, Inc. (CUE)
NASDAQ
Cue Biopharma, Inc. annual/quarterly total liabilities history from 2018 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Cue Biopharma, Inc. total liabilities for the quarter ending December 31, 2025 were 15.8M, a 7.41% increase year-over-year.
- Cue Biopharma, Inc. total liabilities for 2025 were 15.8M, a 7.41% increase from 2024.
- Cue Biopharma, Inc. total liabilities for 2024 were 14.7M, a 39.90% decrease from 2023.
- Cue Biopharma, Inc. total liabilities for 2023 were 24.4M, a 4.52% decrease from 2022.
- Cue Biopharma, Inc. total liabilities for 2022 were 25.6M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Cue Biopharma, Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $16 |
| 2024 | $15 |
| 2023 | $24 |
| 2022 | $26 |
| 2021 | $18 |
| 2020 | $21 |
| 2019 | $17 |
| 2018 | $11 |
| Cue Biopharma, Inc. Quarterly Total Liabilities (Millions of US $) | |
|---|---|
| 2025-12-31 | $16 |
| 2024-12-31 | $15 |
| 2023-12-31 | $24 |
| 2022-12-31 | $26 |
| 2021-12-31 | $18 |
| 2020-12-31 | $21 |
| 2019-12-31 | $17 |
| 2018-12-31 | $11 |
Cue Biopharma, Inc. Total Liabilities — FAQ
Cue Biopharma, Inc. (CUE) total liabilities over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CUE's total liabilities history?
The chart and table above show Cue Biopharma, Inc.'s total liabilities by year and by quarter, including the growth rate.